- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Genovis CEO has sold shares to company where she is co-owner
Sweden | Posted on December 30th, 2010
On December 30, Sarah Fredriksson, CEO sold 522,880 shares in Genovis to NightGlow AB where her holdings amounts to 34%. The other shareholders of NightGlow AB are Fredrik Olsson, COO and Susanne Nykvist, IR / PR manager, all insiders in Genovis.
Genovis is a biotech company on the leading edge of nanotechnology and nanoparticles. The company’s patented nano-induced magnetic transfer (NIMT®) technology was developed to facilitate effective preclinical research for the life science industry. Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission is our certified adviser.
For more information, please click here
Sarah Fredriksson, CEO, Genovis AB Tel: +46 46 10 12 35
Copyright © GenovisIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016
Nanobiotix revenue for Q2 2016 July 14th, 2016